R
ReCept Pharmacy
ReCept Pharmacy has a rich tradition of delivering specialty patient care within the community it has served for over 40 years
About ReCept Pharmacy
In 1978, ReCept Pharmacy was founded by Nicky Otts, establishing itself in the world of specialty pharmacy. The company focused on a unique niche: managing and dispensing complex medications for patients with chronic and difficult-to-treat conditions. This wasn't your typical corner drugstore; ReCept built its business by providing a full suite of services, including managing the entire pharmacy lifecycle from licensing and staffing to handling complex insurance and reimbursement issues for healthcare providers. The playbook was clear: embed within health systems, federally qualified health centers, and large physician groups to manage their on-site specialty pharmacy needs. This model proved effective, as specialty drugs became a rapidly growing and majority share of overall pharmaceutical sales. ReCept provided the specialized tools and expertise that health systems needed to manage these complex patient treatment journeys. A pivotal moment came in December 2021, when Omnicell, a leader in medication management technology, announced it would acquire ReCept Holdings, Inc. for $100 million in cash. At the time of the acquisition, ReCept's business was recording approximately $24 million in annual revenue. The deal was a strategic move for Omnicell to enter the rapidly expanding specialty pharmacy market, complementing its own automated medication management systems with ReCept's hands-on service model.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Dec 2021 | $100M | $100M | Omnicell | ↗ |
| GROWTH EQUITY VCEquity / VC | Dec 2011 | $10M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for ReCept Pharmacy is 810 monthly website visits, up 305% over the last three months. ReCept Pharmacy's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
Omnicell
Generation partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about ReCept Pharmacy on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ReCept Pharmacy’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







